BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang L, Wei S, Zhang J, Hu Q, Hu W, Cao M, Zhang L, Wang Y, Wang P, Wang K. Construction of a predictive model for immunotherapy efficacy in lung squamous cell carcinoma based on the degree of tumor-infiltrating immune cells and molecular typing. J Transl Med 2022;20:364. [PMID: 35962453 DOI: 10.1186/s12967-022-03565-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Shen L, Brown JR, Johnston SA, Altan M, Sykes KF. Predicting response and toxicity to immune checkpoint inhibitors in lung cancer using antibodies to frameshift neoantigens.. [DOI: 10.21203/rs.3.rs-2472861/v1] [Reference Citation Analysis]
2 Zeng L, Li L, Liao X, Zhang L, Yin C, Sun J. Identification of tumor antigens and immune subtypes of early-stage lung squamous cell carcinoma for mRNA vaccine development.. [DOI: 10.21203/rs.3.rs-2219061/v1] [Reference Citation Analysis]